+499.5%
MRNA vs RGEN
+45.2%
+454.3%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | RGEN | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | -1.2% | -1.0% | -1.1% |
| 7D | +5.5% | -4.9% | +10.4% | +9.4% |
| 30D | +158.7% | +5.7% | +153.1% | +155.2% |
| 3M | +182.1% | +32.4% | +149.7% | +146.8% |
| 6M | +151.8% | +33.2% | +118.6% | +117.0% |
| YTD | +393.6% | +2.3% | +391.3% | +406.6% |
| 1Y | +499.5% | +39.0% | +460.5% | +403.8% |
| All | +499.5% | +45.2% | +454.3% | +403.8% |
Cumulative growth
Daily Returns
Daily percentage return beside RGEN.
Daily Out/Under-Performance
Portfolio return minus RGEN return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × RGEN return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded RGEN wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling